<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36051247</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review.</ArticleTitle><Pagination><StartPage>101624</StartPage><MedlinePgn>101624</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101624</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2022.101624</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Although COVID-19 vaccination decreases the risk of severe illness, it is unclear whether vaccine administration may impact the prevalence of long-COVID. The aim of this systematic review is to investigate the association between COVID-19 vaccination and long-COVID symptomatology.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">MEDLINE, CINAHL, PubMed, EMBASE, and Web of Science databases, as well as medRxiv and bioRxiv preprint servers were searched up to June 20, 2022. Peer-reviewed studies or preprints monitoring multiple symptoms appearing after acute SARS-CoV-2 infection either before or after COVID-19 vaccination collected by personal, telephone or electronic interviews were included. The methodological quality of the studies was assessed using the Newcastle-Ottawa Scale.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">From 2584 studies identified, 11 peer-reviewed studies and six preprints were included. The methodological quality of 82% (<i>n</i>=14/17) studies was high. Six studies (<i>n</i>=17,256,654 individuals) investigated the impact of vaccines before acute SARS-CoV-2 infection (vaccine-infection-long-COVID design). Overall, vaccination was associated with reduced risks or odds of long-COVID, with preliminary evidence suggesting that two doses are more effective than one dose. Eleven studies (<i>n</i>=36,736 COVID-19 survivors) investigated changes in long-COVID symptoms after vaccination (infection-long-COVID-vaccine design). Seven articles showed an improvement in long-COVID symptoms at least one dose post-vaccination, while four studies reported no change or worsening in long-COVID symptoms after vaccination.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">Low level of evidence (grade III, case-controls, cohort studies) suggests that vaccination before SARS-CoV-2 infection could reduce the risk of subsequent long-COVID. The impact of vaccination in people with existing long-COVID symptoms is still controversial, with some data showing changes in symptoms and others did not. These assumptions are limited to those vaccines used in the studies.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">The LONG-COVID-EXP-CM study supported by a grant of Comunidad de Madrid.</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Notarte</LastName><ForeName>Kin Israel</ForeName><Initials>KI</Initials><AffiliationInfo><Affiliation>Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catahay</LastName><ForeName>Jesus Alfonso</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Saint Peter's University Hospital, New Brunswick, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velasco</LastName><ForeName>Jacqueline Veronica</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastrana</LastName><ForeName>Adriel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ver</LastName><ForeName>Abbygail Therese</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pangilinan</LastName><ForeName>Flos Carmeli</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peligro</LastName><ForeName>Princess Juneire</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casimiro</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerrero</LastName><ForeName>Jonathan Jaime</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Learning Unit 3, College of Medicine, University of the Philippines Manila, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gellaco</LastName><ForeName>Ma Margarita Leticia</ForeName><Initials>MML</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lippi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Section of Clinical Biochemistry, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>Brandon Michael</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Centre, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long-COVID symptoms</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vaccine</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>2</Day><Hour>2</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36051247</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pii">S2589-5370(22)00354-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis. 2022;114:252&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8595975</ArticleId><ArticleId IdType="pubmed">34800687</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Wang L, Li M, et al. Real-word effectiveness of global COVID-19 vaccines against SARS-CoV-2 variants: a systematic review and meta-analysis. Front Med. 2022;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9160927</ArticleId><ArticleId IdType="pubmed">35665358</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long-COVID: current definition. Infection. 2022;50:285&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz J v. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes LD, Ingram J, Sculthorpe NF. More than 100 persistent symptoms of SARS-CoV-2 (Long-COVID): a scoping review. Front Med. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8591053</ArticleId><ArticleId IdType="pubmed">34790680</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. Characterizing long-COVID: a living systematic review. BMJ Global Health. 2021;6:5427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Int Med. 2021;92:55&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long-COVID: a meta-analysis and systematic review. J Inf Dis. 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Inf. 2022;28:657&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns Hopkins University Coronavirus Resource Centre. COVID-19 dashboard. Published 2022. https://coronavirus.jhu.edu/map.html</Citation></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. FamPract. 2022;39:159&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. Do vaccines protect from long-COVID? Lancet RespirMed. 2022;10:e30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776281</ArticleId><ArticleId IdType="pubmed">35065716</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker N, Ledford H. Coronapod: vaccines and long-COVID, how protected are you? Nature. 2021 doi: 10.1038/d41586-021-03732-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-03732-8</ArticleId><ArticleId IdType="pubmed">34893782</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon AM. Daily briefing: vaccination could reduce long-COVID risk. Nature. 2022 doi: 10.1038/d41586-022-00201-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00201-8</ArticleId><ArticleId IdType="pubmed">35087250</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham F. Daily briefing: what we know about vaccines and long-COVID. Nature. 2021 doi: 10.1038/d41586-021-03531-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-03531-1</ArticleId><ArticleId IdType="pubmed">34880476</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epid. 2009;62:e1&#x2013;e34.</Citation><ArticleIdList><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Tugwell P, O'Connell D, et al. The Newcastle- Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses 2015.</Citation></Reference><Reference><Citation>Simon MA, Luginbuhl RD, Parker R. Reduced incidence of long-COVID symptoms related to administration of covid-19 vaccines both before COVID-19 diagnosis and up to 12 weeks after. medRxiv. Published online 2021. 10.1101/2021.11.17.21263608</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.17.21263608</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom studyapp: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Senjam S, Balhara Y, Kumar P, et al. Assessment of post COVID-19 health problems and its determinants in North India: a descriptive crosssection study. medRxiv. Published online 2021. 10.1101/2021.10.03.21264490</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.03.21264490</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth ML, Statistician &#x2020; Senior, et al. Risk of long-COVID in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study. medRxiv. Published online 2022. 10.1101/2022.02.23.22271388</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.23.22271388</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long-COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022 doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain, Behav, Immun. 2022;103:154&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D, Milne A, Samms E, Stadon L, Maskell N, Hamilton F. Are vaccines safe in patients with Long-COVID? A prospective observational study. medRxiv. Published online 2021. 10.1101/2021.03.11.21253225</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.11.21253225</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaber T, Ashish A, Unsworth A, Martindale J. Are mRNA COVID 19 vaccines safe in long-COVID patients? A health care workers perspective. Br J Med Pract. 2021;14:a008.</Citation></Reference><Reference><Citation>Scherlinger M, Pijnenburg L, Chatelus E, et al. Effect of SARS-CoV-2 vaccination on symptoms from post-acute sequelae of COVID-19: results from the nationwide VAXILONG study. Vaccines. 2021;10:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8781023</ArticleId><ArticleId IdType="pubmed">35062706</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T, Hirose M, Inoue Y, Kunishima H, Otsubo T, Matsuda T. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with long-COVID. J Med Virol. 2022;94:3416&#x2013;3420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9088489</ArticleId><ArticleId IdType="pubmed">35238053</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, de Martino M, Palese A, et al. Post&#x2013;COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients. Clin Microbiol Inf. 2022;28:1140&#x2013;1148. doi: 10.1016/j.cmi.2022.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.03.016</ArticleId><ArticleId IdType="pmc">PMC8940723</ArticleId><ArticleId IdType="pubmed">35339673</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain WD, Sherwood O, Banerjee A, van der Togt V, Hishmeh L, Rossman J. The impact of COVID vaccination on symptoms of long-COVID: an international survey of people with lived experience of long-COVID. Vaccines. 2022;10:652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, et al. Trajectory of long COVID symptoms after COVID-19 vaccination: community based cohort study. BMJ. 2022;377</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H, et al. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. medRxiv. Published online 2022. 10.1101/2022.01.05.22268800</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.05.22268800</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Salamun J, et al. Symptoms after COVID-19 vaccination in patients with post-acute sequelae of SARS-CoV-2. J Gen Int Med. 2022;37:1585&#x2013;1588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863092</ArticleId><ArticleId IdType="pubmed">35194744</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Perrodeau E, Saldanha J, et al. Efficacy of COVID-19 vaccination on the symptoms of patients with long-COVID: a target trial emulation using data from the ComPaRe e-cohort in France. Published online 2021. https://ssrn.com/abstract=3932953</Citation></Reference><Reference><Citation>Wisnivesky JP, Govindarajulu U, Bagiella E, et al. Association of vaccination with the persistence of post-COVID symptoms. J Gen Int Med. 2022;37:1748&#x2013;1753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906626</ArticleId><ArticleId IdType="pubmed">35266128</ArticleId></ArticleIdList></Reference><Reference><Citation>Ontario Agency for Health Protection and Promotion (Public Health Ontario). Impact of vaccination on post-acute COVID-19 syndrome (PACS) &#x2013; what we know so far. 2022.</Citation></Reference><Reference><Citation>Harrison S, Walters B, Zalaya S, Cook M, Clark R. The effectiveness of vaccination against long-COVID: a rapid evidence briefing. 2022.</Citation></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long-covid after Breakthrough COVID-19: the post-acute sequelae of breakthrough COVID-19. Research Square. Published online November 2021.</Citation></Reference><Reference><Citation>Massey D, Berrent D, Krumholz H. Breakthrough symptomatic COVID-19 infections leading to long-COVID: report from long-COVID Facebook group poll. medRxiv. Published online 2021. 10.1101/2021.07.23.21261030</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.23.21261030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Do vaccines protect against long-COVID? What the data say. Nature. 2021;599:546&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">34815580</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G, Diodati F, Puntoni M, et al. Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis. J Clin Med. 2022;11:1541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. The four most urgent questions about long-COVID. Nature. 2021;594:168&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">34108700</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long-COVID or post-acute Sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>